Park Avenue Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$657K	Sell	2,358 -58	-2%	-$16.7K	0.01%	991
2025 Q4	$732K	Sell	2,416 -157	-6%	-$49K	0.01%	938
2025 Q3	$721K	Buy	2,573 +252	+11%	+$68.6K	0.01%	1014
2025 Q2	$560K	Sell	2,321 -70	-3%	-$16.5K	0.01%	1016
2025 Q1	$582K	Buy	2,391 +100	+4%	+$30.1K	0.01%	802
2024 Q4	$753K	Buy	2,291 +504	+28%	+$171K	0.01%	893
2024 Q3	$598K	Sell	1,787 -377	-17%	-$120K	0.01%	911
2024 Q2	$591K	Sell	2,164 -56	-3%	-$16.3K	0.01%	892
2024 Q1	$768K	Buy	2,220 +205	+10%	+$67.4K	0.01%	785
2023 Q4	$651K	Sell	2,015 -1,578	-44%	-$495K	0.01%	800
2023 Q3	$1.29M	Buy	+3,593	New	+$1.39M	0.02%	464
2023 Q1	–	Sell	-3,067	Closed	-$1.29M	–	749
2022 Q4	$1.29M	Buy	3,067 +298	+11%	+$120K	0.02%	419
2022 Q3	$1.16M	Buy	2,769 +175	+7%	+$87.3K	0.02%	404
2022 Q2	$1.28M	Buy	2,594 +342	+15%	+$178K	0.02%	381
2022 Q1	$1.27M	Sell	2,252 -57	-2%	-$34.4K	0.02%	399
2021 Q4	$1.75M	Buy	2,309 +33	+1%	+$24.7K	0.03%	302
2021 Q3	$1.7M	Buy	2,276 +85	+4%	+$63.7K	0.03%	276
2021 Q2	$1.41M	Buy	2,191 +108	+5%	+$65.7K	0.03%	294
2021 Q1	$1.19M	Buy	2,083 +568	+37%	+$336K	0.03%	295
2020 Q4	$883K	Buy	1,515 +122	+9%	+$69.5K	0.02%	321
2020 Q3	$718K	Buy	1,393 +169	+14%	+$85.6K	0.02%	305
2020 Q2	$553K	Buy	1,224 +407	+50%	+$180K	0.02%	371
2020 Q1	$286K	Buy	817 +117	+17%	+$43K	0.02%	244
2019 Q4	$259K	Buy	+700	New	+$247K	0.01%	504